HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Selway Selected Research

Status Epilepticus (Complex Partial Status Epilepticus)

1/2023Perspective: Vagal nerve stimulation in the treatment of new-onset refractory status epilepticus.
1/2023Safe and effective implantation and use of vagal nerve stimulation in new-onset refractory status epilepticus in early pregnancy: a case report.
3/2021Low frequency centromedian thalamic nuclei deep brain stimulation for the treatment of super refractory status epilepticus: A case report and a review of the literature.
9/2019Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES - Two different outcomes.
8/2015Epilepsia partialis continua responsive to neocortical electrical stimulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard Selway Research Topics

Disease

15Dystonia (Limb Dystonia)
12/2022 - 08/2011
9Dystonic Disorders (Writer's Cramp)
04/2021 - 08/2011
5Status Epilepticus (Complex Partial Status Epilepticus)
01/2023 - 08/2015
4Cerebral Palsy (Spastic Diplegia)
01/2020 - 01/2017
3Seizures (Absence Seizure)
09/2019 - 01/2014
3Epilepsy (Aura)
02/2015 - 01/2013
2Drug Resistant Epilepsy
03/2022 - 10/2013
2Motor Disorders
02/2021 - 08/2011
2Neoplasms (Cancer)
02/2021 - 06/2017
2Movement Disorders (Movement Disorder)
01/2021 - 01/2017
2Pain (Aches)
01/2020 - 09/2012
2Parkinson Disease (Parkinson's Disease)
03/2014 - 01/2014
1Clinical Deterioration
12/2023
1Glioma (Gliomas)
02/2021
1Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome)
02/2021
1Inborn Genetic Diseases (Disease, Hereditary)
02/2021
1Parkinsonian Disorders (Parkinsonism)
12/2020
1Dysphonia (Spastic Dysphonia)
12/2020
1Vomiting
11/2019
1Cicatrix (Scar)
04/2018
1Inflammation (Inflammations)
06/2017
1Infections
01/2017
1Dyskinesias (Dyskinesia)
01/2017
1Deafness (Deaf Mutism)
01/2017
1Epilepsia Partialis Continua
08/2015
1Glossopharyngeal Nerve Diseases (Glossopharyngeal Neuralgia)
02/2015
1Sudden Unexpected Death in Epilepsy
02/2015
1Neurodegeneration with brain iron accumulation (NBIA)
06/2013
1Contracture
06/2013
1Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
03/2011
1Hamartoma
10/2003

Drug/Important Bio-Agent (IBA)

21- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimideIBA
01/2018 - 08/2011
1Anesthetics (Anesthetic Agents)IBA
01/2023
1PolyphenolsIBA
02/2021
1EnzymesIBA
02/2021
1Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
02/2021
1Proteins (Proteins, Gene)FDA Link
12/2020
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
09/2019
1Anticonvulsants (Antiepileptic Drugs)IBA
09/2019
1BaclofenFDA LinkGeneric
04/2018
1HemosiderinIBA
06/2017
1erucylphosphocholineIBA
08/2015
1Therapeutic UsesIBA
02/2015
1Glycerol (Glycerine)FDA LinkGeneric
02/2015
12,6-dinitrotoluene (DNT)IBA
01/2014
1IronIBA
05/2013

Therapy/Procedure

27Deep Brain Stimulation
12/2022 - 03/2011
6Electrodes (Electrode)
12/2022 - 05/2013
4Vagus Nerve Stimulation
01/2023 - 02/2015
2Therapeutics
09/2019 - 01/2014
1Ventriculoperitoneal Shunt
12/2023
1Drug Therapy (Chemotherapy)
01/2023
1General Anesthesia
04/2021
1Behavior Control
02/2021
1Analgesia
01/2020
1Reoperation
04/2018
1Cochlear Implantation
01/2017
1Implanted Electrodes
05/2013
1Self-Help Devices (Assistive Technology)
09/2012
1Electrocoagulation (Electrocautery)
10/2003